+7 495 640-17-71



Important news

We are pleased to invite you in our stand z4d41, to explore innovations of PCR technology. Reserve a time slot sending request to info@dna-technology.com
We are looking forward to meeting you!


“DNA-Technology” has completed the quality assessment study of SARS-CoV-2 molecular detection coordinated by Quality Control for Molecular Diagnostics (QCMD), UK. The Panel  Composition included Alpha, Beta SARS-CoV-2 Variants, etc. The correct result was obtained in 100% of cases.


First outbreak of the Candida auris, type of yeast or fungi, has been reported recently in the Texas and Washington, USA (source). This fungus is not dangerous for the people with strong immune system, but can be a big problem for those with the impaired immunity – people with chronic or opportunistic diseases.


All news

Experts from the World Health Organization have checked the quality of PCR analysis performed by the Biomedica laboratory (the Company's partner in Georgia). Reagents kits for the detection of SARS-CoV-2 manufactured by DNA-Technology received the highest rating as the most accurate test system. The report can be found here


Our company has received a confirmation of the fulfillment of applicable requirements of the European Council Directive 98/79/EC and now officially holds the right to affix CE marking on the following products:


We are pleased to announce the launch of our new AVRI Panel Multiplex PCR kit.  The kit can be used in the research practice and does not depend on population and demographic aspects. More information about the kit is available on the product page


New research that was aimed to investigate molecular basis of the vaginal microbiome applying the Femoflor® 16 test system in women with nonspecific colpitis has become available on the website under Study Guides section. As a result of the extensive research, authors have confirmed that the real-time PCR-based Femoflor® 16 test system provides results corresponding to those of conventional microbiology regarding the assessment of the vaginal flora state. For more information on the research summary report click here.


In this publication we offer to review the results of a study conducted under the guidance of Professor Ekaterina Voroshilina, Doctor of Medical Sciences, presented during the international conference ESHRE ’s 37th virtual Annual Meeting 2021 (European Society for Human Reproduction and Embryology).


Dear partners,

“DNA-Technology” will be closed for public holidays from May 1 to May 10, 2021. We will resume our regular work on the May 11. Please, consider this information for your workflow plans.


We are pleased to present a new article "Differential Expression of Local Immune Response Genes in the Vagina: Implication for the Diagnosis of Vaginal Infections" by A. M. Savicheva with a group of authors from D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology and St. Petersburg State Pediatric Medical University, St. Petersburg.


Dear Partners,

With 2020 a year comes to its end, which is nothing less than a break in history of our planet. The pandemic directly or indirectly affected the entire mankind. In these times, we are blessed and thankful, having you as partners and friends on our side.


Dear colleagues!
We are pleased to announce that we have created a new booklet "Femoflor: brief Introduction", which has collected answers to the most frequently asked clinical questions regarding the diagnosis of reproductive tract infections.
Why do you need Femoflor®, if you have a microscopy? What are the indications for Femoflor®-screen and Femoflor®-16 tests? How to read the report? Is it possible to use Femoflor® for men?